GNRSU stock drops 99.999% to $0.000001 on PNK: key risks for traders

GNRSU stock collapsed 99.999% to $0.000001 on the PNK exchange on 13 Feb 2026, making it one of today’s top losers in the United States market. The Greenrose Holding Company Inc. (GNRSU) recorded just 145 shares traded and a market cap reported at $13.00, driven by extreme illiquidity and a gap from a prior close of $0.15. We examine the drivers behind the move, connect key financial ratios to price action, and outline why this microcap remains high risk during market hours.

Market move: GNRSU stock collapse and trading snapshot

The largest immediate driver is the price drop of 99.99933% from the previous close of $0.15 to $0.000001 on PNK, with volume 145 indicating very thin trading. There is no posted earnings announcement for today, and the drop looks driven by microcap illiquidity, potential corporate action or delisting pressure rather than fresh operational results.

Fundamentals: GNRSU stock financials and ratios

Greenrose Holding Company Inc. reports EPS $3.10 and an anomalous reported P/E near 0.00000032 due to the collapsed price; shares outstanding are 12,853,627. Key balance metrics show book value per share $4.30, current ratio 0.21, and working capital deeply negative at -$103,434,000, which highlights solvency and liquidity pressures despite reported per-share earnings.

Liquidity and valuation: GNRSU stock technical and market metrics

Price averages show a 50-day and 200-day average of $0.15, underscoring how far the trade has moved from prior levels; market cap is reported as $13.00 and enterprise value metrics in the data suggest reporting anomalies. Low daily volume and a day high/day low of $0.000001 signal high volatility and severe bid-ask risk for active traders.

Meyka AI rates GNRSU with a score out of 100 and valuation view

Meyka AI rates GNRSU with a score out of 100: 66.94 | Grade: B | Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst signals. We caution this is informational; grades are not guarantees and not financial advice.

Catalysts, risks and GNRSU stock outlook

Primary risks are OTC listing status, potential corporate actions, and cash/working capital strain given debt-to-equity 1.57 and negative tangible book value. Upside catalysts would be operational news restoring liquidity, asset sales, or corporate restructuring; absent that, downside and delisting risk remain elevated.

Trading strategy and GNRSU stock short-term setup

For traders, GNRSU stock represents a high-risk microcap with extreme spread and execution risk; put simply, size your position small and expect outsized moves. Use limit orders, monitor filings and OTC announcements, and treat any attempt to trade GNRSU as speculative given current market conditions and limited volume.

Final Thoughts

Key takeaways: GNRSU stock is a top loser on 13 Feb 2026 after a 99.99933% intraday collapse to $0.000001 on the PNK exchange. Fundamentals show mixed per-share earnings versus weak liquidity and negative working capital, while technicals point to severe trading risk with only 145 shares traded today. Meyka AI’s forecast model projects a recovery scenario to $0.10 over a 12-month horizon, implying an upside of roughly 9,999,900.00% from the current quoted price; forecasts are model-based projections and not guarantees. Given the firm’s negative working capital and microcap listing, our view is cautious: any speculative exposure should be tiny, with strict risk controls and attention to company filings and OTC status. For further context, see the company website and profile data Greenrose Holding Company and the company symbol image/data FinancialModelingPrep GNRSU. Meyka AI provides this as an AI-powered market analysis platform and the grade above reflects multi-factor comparison, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.